alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
<TABLE> <S> <C>


<ARTICLE>                                            9
<MULTIPLIER>                                   1,000
       
<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                              DEC-31-1998
<PERIOD-START>                                 JAN-01-1998
<PERIOD-END>                                   MAR-31-1998
<CASH>                                         586
<INT-BEARING-DEPOSITS>                         39
<FED-FUNDS-SOLD>                               11,800
<TRADING-ASSETS>                               0
<INVESTMENTS-HELD-FOR-SALE>                    2,985
<INVESTMENTS-CARRYING>                         0
<INVESTMENTS-MARKET>                           0
<LOANS>                                        18,530
<ALLOWANCE>                                    30
<TOTAL-ASSETS>                                 34,851
<DEPOSITS>                                     30,222
<SHORT-TERM>                                   0
<LIABILITIES-OTHER>                            159
<LONG-TERM>                                    0
<PREFERRED-MANDATORY>                          0
<PREFERRED>                                    0
<COMMON>                                       0
<OTHER-SE>                                     4,470
<TOTAL-LIABILITIES-AND-EQUITY>                 34,851
<INTEREST-LOAN>                                374
<INTEREST-INVEST>                              112
<INTEREST-OTHER>                               0
<INTEREST-TOTAL>                               486
<INTEREST-DEPOSIT>                             284
<INTEREST-EXPENSE>                             284
<INTEREST-INCOME-NET>                          202
<LOAN-LOSSES>                                  0
<SECURITIES-GAINS>                             0
<EXPENSE-OTHER>                                137
<INCOME-PRETAX>                                68
<INCOME-PRE-EXTRAORDINARY>                     0
<EXTRAORDINARY>                                0
<CHANGES>                                      0
<NET-INCOME>                                   47
<EPS-PRIMARY>                                  0
<EPS-DILUTED>                                  0
<YIELD-ACTUAL>                                 3.05
<LOANS-NON>                                    0
<LOANS-PAST>                                   0
<LOANS-TROUBLED>                               0
<LOANS-PROBLEM>                                0
<ALLOWANCE-OPEN>                               30
<CHARGE-OFFS>                                  0
<RECOVERIES>                                   0
<ALLOWANCE-CLOSE>                              30
<ALLOWANCE-DOMESTIC>                           30
<ALLOWANCE-FOREIGN>                            0
<ALLOWANCE-UNALLOCATED>                        0
        


</TABLE>
EXHIBIT 13.1 CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 In connection with the Annual Report of China Linen Textile Industry, Ltd. (the "Company") on Form 20-F for the fiscal year ended December 31, 2008, as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Gao Ren, President and Chairman of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that: (1)The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and(2)The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.  /s/ Gao RenGao Ren, President and Chairman July 14, 2009
Searched for **http://www.cdc.gov/cdctv/diseaseandconditions/vaccination/h1n1-vaccine-anne-schuchat.html**

 

19961997199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024

*Note:* This calendar view maps the number of captures of **http://www.cdc.gov/cdctv/diseaseandconditions/vaccination/h1n1-vaccine-anne-schuchat.html**, *not* how many times the site was actually updated.

Look Up URL in general Internet Archive web collection.
- Bureau of the Fiscal Service
- Direct Deposit (Electronic Funds Transfer)
- Reports and Statistics

# Reports & Statistics

Download reports that compare monthly and cumulative Direct Deposit (Electronic Funds Transfer) payment volumes for different time periods.
            - FY 2023
            - FY 2022
            - FY 2021
            - FY 2020
            - FY 2019
            - FY 2018
            - FY 2017
            - FY 2016
            - FY 2015
            - FY 2014
            - FY 2013
            - FY 2012
            - FY 2011
            - FY 2010
            - FY 2009
            - FY 2008
            - FY 2007

SSA & SSI Check Recipients
            -  SSA Check Recipients via SSA website
            - SSI Check Recipients via SSA website

Last modified 10/16/23
No. 59954.—Suit 4851.

#### United States *v.*Damrak Trading Co., Inc.

C. A. D. 611.
ARMED SERVICES BOARD OF CONTRACT APPEALS 

Appeal of -- ) 

) 

Great America Construction Company ) 

) 

Under Contract No. W56SGK-13-C-0002 ) 

APPEARANCE FOR THE APPELLANT: 

APPEARANCES FOR THE GOVERNMENT: 

ASBCA No. 60674 

Mr. Mansour Alamyar 

Vice President 

Raymond M. Saunders, Esq. 

Army Chief Trial Attorney 

CPT Douglas A. Reisinger, JA 

Trial Attorney 

ORDER OF DISMISSAL 

By Order dated 18 July 2016, the Board requested that appellant provide a copy of 

the claim it had submitted to the contracting officer prior to the filing of this appeal. In 

response, appellant indicated that it desired to submit its claim to the contracting officer 

for a decision. The government provided appellant with the contact information for the 

cognizant contracting officer and appellant submitted a claim to the contracting officer. 

By Order dated 2 August 2016, the Board informed the parties that it intended to dismiss 

this appeal unless either party objected within 14 days of the date of the Order. The 

Board has not received an objection from either party. 

Accordingly, this appeal is dismissed without prejudice to any appeal from the 

contracting officer's final decision or deemed denial of the contractor's claim. 

Dated: 24 August 2016 

~~-~ 

Administrative Judge 

Acting Chairman 

Armed Services Board 

of Contract Appeals 
I certify that the foregoing is a true copy of the Order of Dismissal of the Armed 

Services Board of Contract Appeals in ASBCA No. 60674, Appeal of Great America 

Construction Company, rendered in conformance with the Board's Charter. 

Dated: 

2 

JEFFREY D. GARDIN 

Recorder, Armed Services 

Board of Contract Appeals
In the United States Court of Federal Claims 

OFFICE OF SPECIAL MASTERS

* * * * * * * * * * * * * * * * * * * * * 

GAIL ROSS and CATHERINE * 

MCDOWELL, parents of * No. 14-90V 

M.R., a minor, * Special Master Christian J. Moran 

 * 

 Petitioner, * 

 * 

v. * Filed: September 14, 2015 

 * 

SECRETARY OF HEALTH * Stipulation; influenza (“flu”) vaccine; 

AND HUMAN SERVICES, * narcolepsy. 

 * 

 Respondent. * 

* * * * * * * * * * * * * * * * * * * * * 

Ronald Craig Homer, Conway, Homer & Chin-Caplan, P.C., Boston, MA, for 

Petitioners; 

Heather Pearlman, U.S. Dep’t of Justice, Washington, DC, for Respondent. 

UNPUBLISHED DECISION1

 On September 11, 2015, the parties filed a joint stipulation concerning the 

petition for compensation filed by Gail Ross and Catherine McDowell on behalf of 

M.R. on January 30, 2014. In the petition, petitioners alleged that the influenza 

vaccine, which is contained in the Vaccine Injury Table (the “Table”), 42 C.F.R. 

§100.3(a), and which she received on November 18, 2011, caused M.R. to suffer 

narcolepsy. Petitioner further alleges that she suffered the residual effects of this 

injury for more than six months. Petitioners represent that there has been no prior 

award or settlement of a civil action for damages on M.R.’s behalf as a result of 

M.R.’s condition. 

 

1 The E-Government Act of 2002, Pub. L. No. 107-347, 116 Stat. 2899, 2913 (Dec. 17, 

2002), requires that the Court post this decision on its website. Pursuant to Vaccine Rule 18(b), 

the parties have 14 days to file a motion proposing redaction of medical information or other 

information described in 42 U.S.C. § 300aa-12(d)(4). Any redactions ordered by the special 

master will appear in the document posted on the website. 
2 

Respondent denies that the influenza vaccine caused petitioner to suffer 

narcolepsy or any other injury. 

 Nevertheless, the parties agree to the joint stipulation, attached hereto as 

Appendix A. The undersigned finds said stipulation reasonable and adopts it as the 

decision of the Court in awarding damages, on the terms set forth therein. 

 

Damages awarded in that stipulation include: 

A lump sum payment of $213,045.24 in the form of a check payable to 

petitioners, Gail Ross and Catherine McDowell, as 

guardians/conservators of M.R.’s estate. This amount represents 

compensation for all damages that would be available under 42 U.S.C. § 

300aa-15(a). 

A lump sum payment of $16,954.76 payable to petitioners Gail Ross and 

Catherine McDowell, which represents compensation for past 

unreimbursable expenses. 

 In the absence of a motion for review filed pursuant to RCFC, Appendix B, 

the clerk is directed to enter judgment in case 14-90V according to this decision 

and the attached stipulation.2

 

 Any questions may be directed to my law clerk, Shannon Proctor, at (202) 

357-6360. 

 

IT IS SO ORDERED. 

 

 s/Christian J. Moran 

 Christian J. Moran 

 Special Master 

 

2 Pursuant to Vaccine Rule 11(a), the parties can expedite entry of judgment by each 

party filing a notice renouncing the right to seek review by a United States Court of Federal 

Claims judge.
Page 1
                                  Delaware

                     ----------------------------------
                               The First State

         I, HARRIET SMITH WINDSOR, SECRETARY OF STATE OF THE STATE OF DELAWARE
, DO HEREBY CERTIFY THE ATTACHED IS A TRUE AND CORRECT COPY OF THE CERTIFICATE
OF AMENDMENT OF " ON THE GO HEALTHCARE,INC.", FILED IN THIS OFFICE ON THE
TWENTY-SECOND DAY OF SEPTEMBER A.D. 2004, AT  8:18 O'CLOCK P.M.

         A FILED COPY OF THIS CERTIFICATE HAS BEEN FORWARDED TO THE NEW CASTLE
COUNTY RECORDER OF DEEDS.







                                      /s/ HARRIET SMITH WINDSOR
                          [SEAL]      -----------------------------------
                                      HARRIET SMITH WINDSOR, Secretary of State


3263360  8100                                      AUTHENTICATION:    3368198

040687405                                                   DATE:    09-23-04

<PAGE>


           CERTIFICATE OF AMENDMENT TO THE RESTATED CERTIFICATE OF
                               INCORPORATION
                        OF ON THE GO HEALTHCARE, INC.

On The Go Healthcare, Inc., filed a certificate of incorporation with the
Secretary of State of Delaware on July 21, 2000.  A Restated Certificate of
Incorporation was filed on July 14, 2004.  Following is an Amendment to the
Restated Certificate of Incorporation.

It is hereby certified that:

1. The name of the corporation(the "Corporation") is On The Go Healthcare, Inc.

2. The Restated Certificate is hereby amended by adding the following new
   Article THIRTEENTH:

THIRTEENTH:

Every 30 issued and outstanding share of Common Stock of the Corporation will
be combined into and automatically become one (1) outstanding share of Common
Stock of the Corporation and the authorized shares of the Corporation shall
remain as set forth in these Articles of Incorporation. No fractional share
shall be issued in connection with the foregoing stock split; all shares of
Common Stock so split that are held by a stockholder will be aggregated
subsequent to the foregoing split and each fractional share resulting from
such aggregation of each series held by a stockholder shall be rounded up to
the nearest whole share.

3. The amendment to this Restated Certificate of Incorporation herein certified
   has been duly adopted in accordance with the provisions of Section 242 of
   the General Corporation Law of the State of Delaware.


Signed this 22 day of September, 2004



ON THE GO HEALTHCARE, INC.

/s/ Stuart Turk
-------------------------
Stuart Turk
President, Chief Executive Officer

<PAGE>
Exhibit 13.1 CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002  In connection with the Form 20FR12G Registration Statement of Aquasol Envirotech Ltd. for the year ended March 31, 2006, as filed with the Securities and Exchange Commission on the date hereof (the Annual Report), I hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:  1.The Annual Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and2.The information contained in the Annual Report fairly presents, in all material respects, the financial condition and results of operations of the registrant.  Date: September 25, 2006   "Ken Z. Cai " Ken Z. Cai Chairman of The Board & Director
Document

Exhibit 10.49

AMENDMENT No. 2
NEXTIER OILFIELD SOLUTIONS INC. 
EQUITY AND INCENTIVE AWARD PLAN


WHEREAS, NexTier Oilfield Solutions Inc. (the “Company”) maintains the “NexTier Oilfield Solutions Inc. Equity and Incentive Award Plan” (as amended to date, the “Plan”), which was originally adopted by the Company’s predecessor, Keane Group, Inc. (“Keane”), and approved by its stockholders, to provide equity compensation awards to its key employees; 


WHEREAS, in December 2020, the Company amended the Plan to increase the total number of authorized shares by 7 million shares of the Company’s common stock;


WHEREAS, in connection with the merger of C&J Energy Services, Inc.(“C&J”) and Keane, the Company assumed and now maintains the NexTier Oilfield Solutions Inc. (former C&J Energy) Management Incentive Plan (the “MIP”), which was originally adopted by C&J and approved by its stockholders;


WHEREAS, pursuant to Section 11.5 of the MIP, the MIP may be amended by the Board at any time; 


            WHEREAS, pursuant to Section 11.2 of the Plan, the Plan may be amended at any time by the Board or the Committee;


WHEREAS, the Company desires to amend the MIP to reduce the total number of authorized shares by 4,750,000 million shares of the Company’s common stock, and desires to amend the Plan to increase the total number of authorized shares by 8,055,722 million shares of the Company’s common stock;


NOW THEREFORE, the Company hereby amends Section 2.1(a) of the Plan as follows:


1.Amendment to Section 2.1(a):


“Subject to Section 11.3 and Section 2.1(b), the aggregate number of shares of Common Stock that may be issued or transferred pursuant to Awards under the Plan shall be equal to 26,990,323 shares (the “Authorized Shares”).”


2.The remainder of Section 2.1 of the Plan shall remain unchanged.


3.This Amendment only amends and modifies the Plan to the extent specifically provided herein.  All terms, conditions, provisions and references of the Plan that are not specifically modified remain in full force and effect.
Exhibit 32.1

CERTIFICATION PURSUANT TO SECTION 906  OF THE SARBANES-OXLEY ACT OF 2002

In connection with the quarterly report on Form 10-Q of Nutraceutical International Corporation (the "Company") for the period ended
March 31, 2004 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Frank W. Gay II, Chairman of the Board and Chief Executive Officer of the Company,
certify, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge:



|/s/FRANK W. GAY IIFrank W. Gay II
Chairman of the Board
and Chief Executive Officer |  | 
|----------------------------------------------------------------------------------- |  | 
|Date: April 29, 2004                                                                |  | 

CERTIFICATION PURSUANT TO SECTION 906  OF THE SARBANES-OXLEY ACT OF 2002

In connection with the quarterly report on Form 10-Q of Nutraceutical International Corporation (the "Company") for the period ended
March 31, 2004 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Leslie M. Brown, Jr., Senior Vice President, Finance, Chief Financial Officer and
Assistant Secretary of the Company, certify, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge:



|/s/LESLIE M. BROWN, JR.Leslie M. Brown, Jr.
Senior Vice President, Finance,
Chief Financial Officer and Assistant Secretary |  |  |  | 
|--------------------------------------------------------------------------------------------------------------------------- |  |  |  | 
|Date: April 29, 2004                                                                                                        |  |  |  | 

Signed
originals of these written statements required by Section 906 have been provided to the Company and will be retained by the Company and furnished to the Securities and
Exchange Commission or its staff upon request.

---



QuickLinks
Before the Second Division,

August 4, 1948

No. 52486.

protests 786727-G, etc. (New York).

#### Oppenheim Collins et al. *v.*United States,

Opinion by

Lawrence, J.

It was stipulated that the merchandise is the same in all material respects as the gloves which were the subject of *United States*v. *Julius Kayser & Co.*(33 C. C. P. A. 179, C. A. D. 333). The claim at 50 percent ad valorem under paragraph 915, plus any additional duty applicable under paragraph 924, was therefore sustained.
No. 59413.

protests 231437-K, etc. (New York).

#### Quality Importers, Inc., et al. *v.*United States,

Opinion by

Johnson, J.

In accordance with stipulation of counsel that the merchandise and issues are similar in all material respects to those involved in *United States*v. *R. C. Williams & Co., Inc.*(40 C. C. P. A. 130, C. A. D. 508) and *Austin, Nichols & Co., Inc.*v. *United States*(22 Cust. Ct. 33, C. D. 1155), the claim of the plaintiffs was sustained.
UNPUBLISHED

UNITED STATES COURT OF APPEALS

FOR THE FOURTH CIRCUIT

No. 96-7218

LITTLE TOM CHILDRESS,

Plaintiff - Appellant,

versus

J. ERVINE; CALVIN GREGORY; D. MASTERSON; OFFICER FERGUSON; OFFICER ASSENAT,

Defendants - Appellees.

No. 96-7219

LITTLE TOM CHILDRESS,

Plaintiff - Appellant,

versus

J. ERVINE; RAYMON MORROW, a/k/a Morrison;

ROANOKE CITY JAIL, Sheriff's Department,

Defendants - Appellees.

Appeals from the United States District Court for the Western District of Virginia, at Roanoke. Glen E. Conrad, Magistrate Judge.

(CA-95-575-R, CA-95-184-R)

Submitted: December 12, 1996 Decided: December 19, 1996
2
3

Before MURNAGHAN, NIEMEYER, and LUTTIG, Circuit Judges.

Affirmed by unpublished per curiam opinion.

Little Tom Childress, Appellant Pro Se. Robert F. Rider, RIDER,

THOMAS, CLEAVELAND, FERRIS & EAKIN, Roanoke, Virginia, for

Appellees.

Unpublished opinions are not binding precedent in this circuit.

See Local Rule 36(c).

PER CURIAM:

Appellant appeals the magistrate judge's entry of judgment by

jury denying relief on his consolidated 42 U.S.C. § 1983 (1994)

complaints. We have considered the issues Appellant raised in his

informal brief, reviewed the record and the district court's judgment, and find no reversible error. Accordingly, we affirm the

denial of relief under § 1983. Because there are no complex or

substantial issues presented in these appeals, we deny Appellant's

motions for appointment of counsel. We dispense with oral argument

because the facts and legal contentions are adequately presented in

the materials before the court and argument would not aid the decisional process.

AFFIRMED
4
```

[Congressional Bills 115th Congress]
[From the U.S. Government Publishing Office]
[H. Res. 721 Introduced in House (IH)]

<DOC>

115th CONGRESS
  2d Session
H. RES. 721

  Expressing support for designation of February 4, 2018, as National 
                         Cancer Prevention Day.

_______________________________________________________________________

                    IN THE HOUSE OF REPRESENTATIVES

                            February 2, 2018

 Mrs. Dingell (for herself and Mrs. Comstock) submitted the following 
 resolution; which was referred to the Committee on Energy and Commerce

_______________________________________________________________________

                               RESOLUTION

 
  Expressing support for designation of February 4, 2018, as National 
                         Cancer Prevention Day.

Whereas National Cancer Prevention Day is a day to remind us that when looking 
        at cancer we need to look at prevention and reducing risks for human 
        health and the environment;
Whereas when we work to prevent cancer risks, it impacts human health, the 
        environment, and the economy;
Whereas cancer is one of the leading causes of death around the world and has 
        touched the lives of nearly everyone, either directly or indirectly;
Whereas the disease is the cause of nearly 1 out of every 4 deaths in the United 
        States;
Whereas in 2018, there will be an estimated 1,735,350 new cancer cases diagnosed 
        and 609,640 cancer deaths in the United States;
Whereas cancer is the second most common cause of death among children ages 1 to 
        14 years in the United States after accidents, and in 2018 an estimated 
        10,590 children in this age group will be diagnosed with cancer and 
        1,180 will die from it; and
Whereas February 4, 2018, would be an appropriate date to designate as Cancer 
        Prevention Day: Now, therefore, be it
    Resolved, That the House of Representatives--
            (1) supports the designation of National Cancer Prevention 
        Day;
            (2) recognizes all efforts to raise the awareness for the 
        reduction of cancer risks; and
            (3) recognizes the devastating effect cancer has on 
        families and wishes to expand knowledge, encourage early 
        detection, and work with friends in the medical and scientific 
        fields to put an end to this deadly disease.
                                 <all>
```
|EXHIBIT 32.2
|------------



|CERTIFICATIONS PURSUANT TO 18 U.S.C. SECTION 1350,AS ADOPTED PURSUANT TO SECTION 906OF THE SARBANES-OXLEY ACT OF 2002
|---------------------------------------------------------------------------------------------------------------------

The undersigned hereby certifies in his capacity as Chief Financial Officer of Belair Capital Fund LLC (the Fund), that based on his knowledge:

|(a) | the Quarterly Report of the Fund on Form 10-Q for the quarter ended June 30, 2005 (the Report) fully complies with the requirements of Section 13(a) of the Securities Exchange Act of 1934, as amended; and
|--- | ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
|   
|(b) | the information contained in the Report fairly presents, in all material respects, the financial condition and the results of operations of the Fund for such period.                                       
|   



|Date: August 9, 2005
|--------------------



| | /s/ James L. O'ConnorJames L. O'ConnorChief Financial Officer
| | -------------------------------------------------------------

A signed original of this written statement required by Section 906 has been provided to the Fund and will be retained by the Fund and furnished to the Securities and Exchange Commission or its staff upon request.

---